Table 3 Doses of four intervention components for the 112 participants in the mFICare group
Intervention component | 3-week study period % (n) | Entire hospitalization % (n) |
|---|---|---|
Paired with a parent mentor | 21% (24) | 29% (32) |
Participation in clinical team rounds | ||
Mean number participated per week (SD) | 4.1 (2.1) | 3.7 (2.0) |
Median number participated per week (IQR) | 4.3 (0–7) | 4.0 (0–7) |
Category | ||
No dose: 0–1 rounds | 6% (7) | 5% (6) |
Low dose: 2–11 rounds | 38% (43) | 22% (25) |
High dose: 12 or more roundsa | 55% (62) | 72% (81) |
Parent group educational classes | ||
Mean number attended (SD) | 3.5 (4.2) | 6.5 (8.7) |
Median number attended (IQR) | 2 (0–11) | 3 (0–30) |
Category | ||
No dose: 0 classes | 30% (34) | 23% (26) |
Low dose: 1–2 classes | 28% (31) | 21% (24) |
High dose: 3 or more classes | 42% (47) | 55% (62) |
mFICare app (We3health™) | ||
Mean number of app logins (SD) | 10.4 (8.1) | 16.3 (15.0) |
Median number of app logins (IQR) | 8 (0–27) | 10 (0–54) |
Category | ||
No dose: 0–3 app logins | 19% (21) | 16% (18) |
Low dose: 4–11 app logins | 44% (49) | 38% (42) |
High dose: 12 or more app logins | 37% (42) | 46% (52) |